Home / Resource Library / Immune responses against SARS-CoV-2 variants after two and three doses of vaccine in B-cell malignancies: UK PROSECO study

Immune responses against SARS-CoV-2 variants after two and three doses of vaccine in B-cell malignancies: UK PROSECO study

Results of a study investigating COVID-19 vaccination efficacy in patients with B-cell blood cancers.